Goldman Sachs’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,549
| Closed | -$7.79K | – | 5312 |
|
|
2023
Q1 | $7.79K | Sell |
30,549
-2,330
| -7% | -$594 | ﹤0.01% | 4976 |
|
|
2022
Q4 | $38.8K | Buy |
+32,879
| New | +$38.8K | ﹤0.01% | 4821 |
|
|
2022
Q2 | – | Sell |
-15,620
| Closed | -$79K | – | 5948 |
|
|
2022
Q1 | $79K | Buy |
+15,620
| New | +$79K | ﹤0.01% | 5374 |
|
|
2021
Q3 | – | Sell |
-130,526
| Closed | -$1.29M | – | 5604 |
|
|
2021
Q2 | $1.29M | Buy |
130,526
+90,986
| +230% | +$899K | ﹤0.01% | 3838 |
|
|
2021
Q1 | $382K | Buy |
+39,540
| New | +$382K | ﹤0.01% | 4517 |
|